Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Share Issue/Capital Change 2018

Mar 22, 2018

3782_rns_2018-03-22_cfd3ade6-b37d-4259-8de0-c6f53b8ee946.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Vistin Pharma ASA : Key information for the subsequent repair issue

Vistin Pharma ASA : Key information for the subsequent repair issue

Reference is made to the stock exchange notice from Vistin Pharma ASA earlier

today, 22 March 2018, regarding a subsequent repair issue of approximately NOK

50 million. Key information for the subsequent repair issue is described below.

---

Date on which the terms and conditions of the subsequent repair issue were

announced: 22 March 2018

Last day including right: 22 March 2018

Ex-date: 23 March 2018

Record Date: 26 March 2018

Date of approval: 9 May 2018

Maximum number of new shares: 4,464,286

Subscription price: NOK 11.20

Will the rights be listed - yes/no: No

Other information: The subsequent repair issue is subject to approval by the

annual general meeting of Vistin Pharma ASA and approval and publication of a

prospectus, expected to take place on or about 11 May 2018.

This information is published in accordance with the requirements of the

Continuing Obligations.